Rankings
▼
Calendar
LQDA FY 2022 Earnings — Liquidia Corporation Revenue & Financial Results | Market Cap Arena
LQDA
Liquidia Corporation
$3B
FY 2022 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$16M
+24.0% YoY
Gross Profit
$13M
82.1% margin
Operating Income
-$39M
-243.3% margin
Net Income
-$41M
-257.4% margin
EPS (Diluted)
$-0.67
Cash Flow
Operating Cash Flow
-$29M
Free Cash Flow
-$29M
Stock-Based Comp.
$9M
Balance Sheet
Total Assets
$129M
Total Liabilities
$39M
Stockholders' Equity
$90M
Cash & Equivalents
$93M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$16M
$13M
+24.0%
Gross Profit
$13M
$10M
+33.0%
Operating Income
-$39M
-$34M
-14.7%
Net Income
-$41M
-$35M
-18.6%
← Q4 2021
All Quarters
Q1 2022 →